While many studies have revealed a pathogenic role of CD4+ T cells and CD40L in other models of MS[27, 65, 66], we have successfully shown the protective role of CD4+ T cells in our previous study and CD40L in the current study. This evidence concerns the gene CD4 and myeloid sarcoma.